Log in to save to my catalogue

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's d...

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733471293

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease

About this item

Full title

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease

Publisher

Cambridge, UK: Cambridge University Press

Journal title

The international journal of neuropsychopharmacology, 2009-11, Vol.12 (10), p.1319-1326

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Alzheimer's disease (AD) can be treated with inhibitors of the enzyme acetylcholinesterase (AChE). There is evidence that AChE inhibitors promote neuroprotective effects and neurogenesis in the central nervous system (CNS). However, the mechanisms by which AChE inhibitors mediate these effects are still not well understood. One possible mechanism c...

Alternative Titles

Full title

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_733471293

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733471293

Other Identifiers

ISSN

1461-1457

E-ISSN

1469-5111

DOI

10.1017/S1461145709990216

How to access this item